Drug Monitoring Assess Panel, Base, Quantitative, Urine
Test Code
Clinical Significance
Drug Monitoring Assess Panel, Base, Quantitative, Urine - A single direct to definitive panel with the ability to identify multiple specific drugs and metabolites across drug classes facilitates enhanced patient care. The test is a definitive assay using liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's ...
Test Resources
Test Summary
Drug Monitoring, Assess Panels, Quantitative, UrineTest Details
If this test code is not ordered with 39158, all medMATCH result codes will be DNR'd.
Amphetamines, Benzodiazepines, Cocaine Metabolite, Fentanyl, Heroin Metabolite, Opiates Expanded
Specimen validity consisting of Creatinine, Oxidant, and pH testing.
Methodology
Reference Range(s)
Preferred Specimen(s)
10 mL random urine collected in a plastic urine container
Minimum Volume
9 mL
Transport Container
Plastic urine container
Transport Temperature
Room temperature
Specimen Stability
- Room temperature: 5 days
Refrigerated: 7 days
Frozen: 30 days
Reject Criteria
Preserved samples
Setup Schedule
Refrigerated: 7 days
Frozen: 30 days